bpc 157 side effects human reports BPC-157 vs TB-500: Complete Comparison (2026) BPC-157 For Knee Pain: Early

While these studies exist, they are even more preliminary than the gastrointestinal and musculoskeletal research

However, avoid excessive doses potentially interfering with necessary acute inflammation

Other peptides under investigation Several additional peptides are being studied for disc-related applications, though with less established evidence: Vasoactive Intestinal Peptide (VIP) has demonstrated the ability to slow disc degeneration progression and improve aggrecan levels in mouse studies

It has been extensively studied for its tissue-healing, anti-inflammatory, and cytoprotective properties across over 100 published research papers

Additionally, vials offer an extent of flexibility during clinical experimentation, which allows for peptide concentrations and combinations to be customised depending on the objective of the investigation